We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Early Ablation Advantageous in Venous Ulceration

By HospiMedica International staff writers
Posted on 14 Oct 2020
Early endovenous ablation of venous leg ulcerations and superficial venous reflux lead to better outcomes, according to a new study. More...


Researchers at Cambridge University Hospitals (United Kingdom), Imperial College London (Imperial; United Kingdom), and other institutions conducted a multi-center, randomized clinical trial involving 450 patients with venous leg ulceration (of less than six months’ duration) and superficial venous reflux. Patients were randomly assigned to early endovenous ablation (224 patients), or deferred endovenous treatment of superficial venous reflux (226 patients). The primary outcome was time to first ulcer recurrence and ulcer recurrence rate.

The results showed that of the 426 participants whose leg ulcer had healed, 28.4% experienced at least one recurrence during follow-up. There was no clear difference in time to first ulcer recurrence between the two groups, but the rate of recurrent ulcers was 60% higher in the deferred intervention group. In addition, the researchers also reported that healing times were shorter in the early intervention group, compared to the deferred intervention group. The study was published on September 23, 2020, in JAMA.

“Venous leg ulcers cause enormous physical and mental distress to patients, as well as having a financial impact on the National Health Service, which spends around two percent of its budget on managing lower limb wounds, and there is an urgent need to find more effective treatments,” said lead author Alun Davies, MD, of Imperial College London. “Our study is the first to show that early surgical treatment of leg ulcers leads to faster healing and the reduced risk of the ulcer coming back compared to current methods.”

Venous ulcers are the result of superficial venous reflux (also known as varicose veins), and tend to occur on the lower leg, just below the ankle to halfway up the calf. Venous ulcers may develop as a result of any injury to the leg or conditions such as varicose vein, a blood clot, multiple pregnancies, overweight, and standing for long periods of time, such as in work related situations. The ulcers are the result of pooling of fluid in the limb, and may include poor wound healing, edema, restricted mobility due to pain or discomfort when moving, and even amputation.


Related Links:
Cambridge University Hospitals
Imperial College London



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.